Linzess (linaclotide) - Ironwood Pharma, AbbVie
Prialt (ziconotide) - Jazz
Resolving conformational polymorphism in disulfide-rich peptide drugs. (PubMed, Front Chem) - Sep 2, 2026 - "Here, cyclic ion mobility-mass spectrometry (cIM-MS), combined with accelerated thermal stress testing, was applied to a manufacturing batch of ziconotide and linaclotide under native and thermally stressed conditions. The high-resolution separation achieved by cIM-MS enabled detailed mapping of coexisting conformers and their stress-induced transitions. These results demonstrate that cIM-MS provides a spatially resolved analytical platform for interrogating higher-order structural heterogeneity in disulfide-rich peptide therapeutics, extending the capabilities of conventional mass spectrometry and offering a generalizable approach for structural characterization and quality assessment." 
Journal
http://www.ncbi.nlm.nih.gov/pubmed/42676398
 
Haiwei Huang; Mingzhe Xu; Shaozhou Zhu; Yifeng Ge
 
Sep 2, 2026
 
Prev Next